BridgeBio Pharma, Inc.
BBIO
24 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Sep 13 9:04 PM | KKR Genetic Disorder L.P. | Proposed Sale | 5,800,000 | $26.95 | $156.3M | — | View → |
← Previous
Page 5 of 5
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17 8:45 PM | Jennifer E. CookDirector | Option Exercise | 83,088 | $16.75 | 34,334(D) | View → |
| May 16, 2026 | May 19 8:27 PM | Neil KumarDirector, Chief Executive Officer | Option Exercise | 71,215 | — | 97,794(D) | View → |
| May 15, 2026 | May 19 8:25 PM | Randal W. ScottDirector | Option Exercise | 10,000 | $16.75 | 21,501(D) | View → |
| Mar 17, 2026 | Mar 19 8:28 PM | Neil KumarDirector, Chief Executive Officer | Grant/Award | 144,883 | $70.94 | 104,313(D) | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Hannah ValantineDirector | Option Exercise | 8,671 | $27.36 | 17,343(D) | View → |
| Mar 4, 2026 | Mar 6 9:57 PM | Andrea EllisDirector | Option Exercise | 64,921 | $8.45 | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:17 PM | Hannah ValantineDirector | Option Exercise | 25,484 | $48.45 | 0(D) | View → |
| Feb 16, 2026 | Feb 18 11:41 PM | Neil KumarDirector, Chief Executive Officer | Option Exercise | 64,698 | — | 138,645(D) | View → |
| Feb 17, 2026 | Feb 18 11:34 PM | Randal W. ScottDirector | Option Exercise | 10,000 | $16.75 | 31,501(D) | View → |